December 15th, 2015

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S (NY: NVO )

72.83 USD +0.31 (+0.43%)
Official Closing Price Updated: 6:59 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Novo Nordisk A/S

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
54 55 Next >
3 Top Diabetes Stocks to Watch in April
Find out why our team of healthcare experts is laser-focused on these diabetes stocks right now. 
Tags ABT DXCM MDT
From Motley Fool
Novo Nordisk Earns Technical Rating Upgrade
Novo Nordisk shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Interesting Junior Gold Miner Tidbit
It’s been a boring few years for gold miners in general and junior gold miners in particular. But under the surface, things are bubbling, as a handful of emerging players put up good numbers and make... 
Tags Basic Materials / Commodities Stocks / Equities Commodities
From Blogs - TalkMarkets
80 Firms Going Ex-Dividend Next Week, Including Cardinal Health, Ventas And State Street Corp.
Ex-dividend dates are important to dividend investors because one must own a stock on its ex-dividend date in order to be eligible to receive its next dividend. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Novo Nordisk Scores Relative Strength Rating Upgrade; Hits Key Threshold
A Relative Strength Rating upgrade for Novo Nordisk shows improving technical performance. 
From Investor's Business Daily
25 Firms going Ex-Dividend next week, including Kohl’s, Best Buy and Medtronic
There are several well known large cap stocks going ex-dividend next week. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Week In Review: Grifols Pays $1.9 Billion For 26% Stake In Shanghai RAAS
Grifols, a Barcelona maker of plasma-based medicines, acquired a 26% stake in Chinese blood plasma company Shanghai RAASfor $1.9 billion in a non-cash deal. Grifols will exchange a 45% ownership in... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Week in Review: Grifols Pays $1.9 Billion for 26% Stake in Shanghai RAAS
Deals and Financings • Grifols of Barcelona acquired a 26% stake in Shanghai RAAS, one of China's largest blood plasma companies, for $1.9 billion; • Ambrx, a San Diego biopharma owned by four China... 
From ChinaBio® Today
Novo Nordisk Launches New Collaborative Innovation Platform in China
Novo Nordisk, a diabetes-focused multinational pharma, has launched INNOVO, a platform designed to promote China innovation by connecting Novo Nordisk with China academic institutions, bio-tech... 
From ChinaBio® Today
REVIEWAPALOOZA!: 5-Stock Samplers
Learning more about picking, about scoring, and about holding yourself accountable. 
Tags GOOG ALKS GOOGL
From Motley Fool
Eli Lilly will offer a half-off version of its popular insulin drug Humalog
Amid increasing pressure on the pharmaceutical industry to lower prices, drugmaker Eli Lilly is planning to sell a cheaper version of Humalog, its popular insulin product. 
Tags NVO General SNY
From MarketWatch
Novo Nordisk files for a label update for Fiasp® to the EMA and the FDA seeking approval for use in children and adolescents
Novo Nordisk today announced that it recently submitted label updates to the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) for Fiasp® (insulin aspart injection) 100... 
From PR Newswire
How You Can Boost Your Stock Market Returns Significantly With A Simple Trick
Many people are unaware that individual stocks display unique seasonal patterns of their own. Is it possible to profitably exploit these? 
Tags Stocks / Equities
From Blogs - TalkMarkets
2 Healthcare Stocks Ripe for a Takeover
Amarin and Aphria could both be bought out soon. 
Tags AMRN Market News APHA
From Motley Fool
Market Trends Toward New Normal in GameStop, Novo Nordisk A/S, Ferroglobe, PC Connection, Nanometrics, and Anavex Life Sciences — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of GameStop Corp. (NYSE:GME),... 
From GlobeNewswire News Releases
Novo Nordisk Is on the Upswing -- for Now
2019 may be a different story. 
Tags Market News NVO
From Motley Fool
Benzinga's Top Upgrades, Downgrades For February 4, 2019
Top Upgrades Morgan Stanley upgraded Intuit Inc. (NASDAQ: INTU) from Underweight to Equal-Weight. Intuit shares fell 0.63 percent ... 
Tags COP SLG YELP
From Benzinga
Novo Nordisk (NVO) Q4 2018 Earnings Conference Call Transcript
NVO earnings call for the period ending December 31, 2018. 
Tags NVO Market News
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates
The year got off to a slow start for the pharma sector from the perspective of regulatory decisions, with the partial government ... 
Tags MRK INCY General
From Benzinga
35 Stocks Moving In Friday's Pre-Market Session
Gainers Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) shares rose 95.1 percent to $2.40 in pre-market trading following late Thursday ... 
Tags PGR MLSS ATAX
From Benzinga
The Benefits Of Seasonal Compounding
A sufficiently large number of shares that are entering strong seasonal trends can be found at any time of the year. That makes it possible to accumulate gains by switching into stocks that are... 
Tags Stocks / Equities
From Blogs - TalkMarkets
Closed-End Funds and Stocks
Closed-end funds tend to be less volatile than single stocks—but not today. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Xultophy® now available in Canada to support improved glycemic control, an issue facing 50 per cent of Canadians with type 2 diabetes
From PR Newswire
3 Top Diabetes Stocks to Watch in January
Diabetes and related conditions affect over 100 million Americans and many more worldwide. Here are three companies helping fight that disease. 
Tags TNDM Market News DXCM
From Motley Fool
Stocks To Watch: Novo Nordisk Sees RS Rating Rise To 85
A Relative Strength Rating upgrade for Novo Nordisk shows improving technical performance. 
From Investor's Business Daily
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
After extended weakness, biotech stocks turned a corner along with the broader markets to close out the week. With just a session left, ... 
Tags Top Stories AZN ACIU
From Benzinga
6 Valuable Pipeline Drugs With Upcoming Catalysts
Heading into December, biotech stocks held up fairly well in 2018. Evaluate Pharma, a firm specializing in data-driven news and analysis ... 
Tags Benzinga Previews VRX
From Benzinga
3 Biotechs With Potential Blockbusters Near the Finish Line
Experimental new drugs at critical stages of development could soon send these stocks screaming in one direction or another. 
Tags Market News GILD VRTX
From Motley Fool
Stocks Generating Improved Relative Strength: Novo Nordisk
A Relative Strength Rating upgrade for Novo Nordisk shows improving technical performance. Will it continue? 
From Investor's Business Daily
Benzinga's Top Upgrades, Downgrades For November 19, 2018
Top Upgrades Analysts at UBS upgraded TD Ameritrade Holding Corp. (NASDAQ: AMTD) from Neutral to Buy. TD Ameritrade shares fell ... 
Tags SCHW VKTX DAL
From Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
54 55 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

3257 Dunmore Rd SE
Medicine Hat, AB T1B 3R2

[P] 403.527.1101
[F] 403.528.5696

Print Advertising: 403.528.5650
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2015 The Medicine Hat News, A Division of Continental Newspapers Canada Ltd.